BBA
IDXX icon

Braun-Bostich & Associates’s Idexx Laboratories IDXX Stock Holding History

Braun-Bostich & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-382
Closed -$206K – 125
2024
Q1 		$206K Sell
382
-214
-36% -$117K 0.17% 122
2023
Q4 		$331K Sell
596
-25
-4% -$11.7K 0.3% 85
2023
Q3 		$272K Buy
+621
New +$310K 0.51% 36
2020
Q4 		– Sell
-710
Closed -$279K – 130
2020
Q3 		$279K Buy
710
+654
+1,168% +$242K 0.28% 55
2020
Q2 		$18K Buy
+56
New +$16.2K 0.02% 178

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Braun-Bostich & Associates's IDXX Position: Q2 2024 in Review

Braun-Bostich & Associates sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 382 shares — an estimated $206K sold.

Braun-Bostich & Associates first reported a position in IDXX in Q2 2020 and held it in 5 quarters. The position peaked at $331K in Q4 2023. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Braun-Bostich & Associates reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Braun-Bostich & Associates sold 382 Idexx Laboratories shares in Q2 2024, an estimated $206K.
  • Braun-Bostich & Associates first reported a position in Idexx Laboratories in Q2 2020 and held it in 5 quarters.
  • Braun-Bostich & Associates's Idexx Laboratories position peaked at $331K in Q4 2023.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Braun-Bostich & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.